Welcome To ONE Regenerative Health
ONE Regenerative Health is pleased to have selected an Amnion Suspension Allograft (ASA) provider with a culture of scientific advancement, a strong commitment to product safety, efficacy and innovation and is dedicated to clinical research.
This ASA injection provider has the first published, multicenter randomized clinical trial evaluating the efficacy of an ASA injection for the treatment of symptomatic knee osteoarthritis.
Amnion Suspension Allograft (ASA) injections
A cryopreserved single-injection therapy that reduces inflammation and pain in Osteoarthritis (OA). (ASA injections are an effective treatment for the nonoperative management of symptomatic OA and other Orthopedic applications for chronic pain and prolonged disease state).
What makes up the Amnion Suspension Allograft ReNu
ReNu consists of amniotic fluid cells and micronized amniotic membrane, and contains three key factors:
– Extracellular matrix (ECM) particles, including hyaluronic acid
– Amniotic fluid cells
– A rich supply of anti-inflammatory cytokines, and regenerative growth factors
“ReNu is a non-steroidal treatment and a single-injection therapy. ASA modulates inflammation without an acute inflammatory response.”
What can ASA be used for?
Conditions We Treat
- Achilles Tendonitis/Tendonosis
- Ankle Sprain or Tear
- Back Pain
- Golfer’s Elbow
- Hip Pain
- Knee Injury and Pain
- Knee MeniscaL Tears
- Low Back Pain (Lumbar Spine)
- Neck Pain (Cervical Spine)
- Shoulder Pain
- Tennis Elbow
Benefits of Regenerative Medicine:
– Minimally Invasive Outpatient procedure
– Avoids surgery
– Minimal to no downtime
– Lower costs than surgery
– Promotes your own body to heal and regenerate
Note: Results can vary by patient
Is ReNu® Safe?
The amniotic tissues in ReNu are collected from fully consented mothers undergoing scheduled caesarean section births of full-term healthy babies. Donors are tested for relevant communicable diseases by an FDA registered laboratory, and Organogenesis only releases tissue for transplantation that has negative or non-reactive results for all tested communicable diseases. After screening, the amniotic tissue is aseptically processed in a controlled, clean environment following strict technical quality assurance standards.